Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04007393 · ClinicalTrials.gov registry record · Phase 2
SMART Use of Medication for the Treatment of Adolescent Severe Obesity
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT04007393: Completed Phase 2 study, sponsored by University of Minnesota.
NCT04007393 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 150 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (13% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04007393, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study will examine the timing and sequence of using adjunct obesity pharmacotherapy for adolescents with severe obesity who do not respond to lifestyle modification therapy alone.
Primary Outcome
The outcome values represent percent change in BMI from baseline to week 48.
Interventions
- DRUG Placebo
- BEHAVIORAL Lifestyle Modification Therapy (LSMT)
- DRUG Phentermine Pill
- DRUG Topiramate Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-11-21 |
| Est. Completion | 2025-03-11 |
| Phase | Phase 2 |
What the finished NCT04007393 record still lists
NCT04007393 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (13% higher).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT04007393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04007393 about?
NCT04007393 is a clinical study titled "SMART Use of Medication for the Treatment of Adolescent Severe Obesity". This study will examine the timing and sequence of using adjunct obesity pharmacotherapy for adolescents with severe obesity who do not respond to lifestyle modification therapy alone.
What is the current status of trial NCT04007393?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2019-11-21. Estimated completion is 2025-03-11.
What interventions are being tested in trial NCT04007393?
The interventions under investigation include: Placebo (DRUG), Lifestyle Modification Therapy (LSMT) (BEHAVIORAL), Phentermine Pill (DRUG), Topiramate Pill (DRUG).
Who is sponsoring clinical trial NCT04007393?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04007393's enrollment target sits among peer trials
150 455th of 2000 higher than 1,510 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI